Clinical characteristics and treatment of IMP-type carbapenemase-producing Enterobacteriaceae bacteremia: Case series and literature review

K Soneda, K Uda, K Araki, T Murakoshi, Y Yuza… - Journal of Infection and …, 2023 - Elsevier
Background Several carbapenemases have been identified globally in Enterobacteriaceae.
In Japan, IMP-type carbapenemase is the most prevalent, although cases of …

Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of …

K Hayakawa, R Nakano, R Hase… - Journal of …, 2020 - academic.oup.com
Abstract Background Carbapenem-resistant Enterobacteriaceae (CRE) are classified as
carbapenemase-producing Enterobacteriaceae (CPE) and non-CPE; the majority of CPE in …

Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015

R Eda, M Nakamura, Y Takayama, S Maehana… - Journal of Infection and …, 2020 - Elsevier
Background The increasing number of carbapenemase-producing Enterobacteriaceae
(CPE) has become a global problem. Most carbapenemases detected in Japan are …

A matched case-case-control study of the impact of clinical outcomes and risk factors of patients with IMP-type carbapenemase-producing carbapenem-resistant …

S Saito, K Hayakawa, S Tsuzuki… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
ABSTRACT IMP-type carbapenemase, found in various Gram-negative bacteria, has been
increasingly detected worldwide. We aimed to study the outcomes and risk factors for …

IMP‐6 Carbapenemase‐Producing Enterobacteriaceae Bacteremia Successfully Treated with Amikacin‐Meropenem in Two Patients

I Nakakura, Y Ogawa, K Sakakura… - … : The Journal of …, 2017 - Wiley Online Library
Infections caused by carbapenemase‐producing Enterobacteriaceae (CPE) are becoming
increasingly common worldwide. Although CPE infections can be fatal, few reports in the …

[HTML][HTML] The molecular and epidemiological characteristics of carbapenemase-producing Enterobacteriaceae isolated from children in Shanghai, China, 2016–2021

P Fu, X Luo, L He, H Rong, C Li, S Chen… - Journal of Microbiology …, 2023 - Elsevier
Background We isolated the carbapenemase-producing Enterobacteriaceae (CPE) strains
from children during 2016–2021 in Shanghai, China and investigated the antimicrobial …

Epidemiology and treatment of carbapenemase-producing Enterobacteriaceae bacteremia in a community hospital setting

S Pang, E Haghshenas… - Official Journal of the …, 2018 - jammi.utpjournals.press
Background: Carbapenemase-producing Enterobacteriaceae (CPE) infections are a rapidly
evolving global threat. With bacteremia mortality rates exceeding 40%, limited consensus …

[HTML][HTML] Development of selective medium for IMP-type carbapenemase-producing Enterobacteriaceae in stool specimens

N Yamamoto, R Kawahara, Y Akeda… - BMC infectious …, 2017 - Springer
Background Identification of carbapenemase-producing Enterobacteriaceae (CPE) in faecal
specimens is challenging. This fact is particularly critical because low-level carbapenem …

Detection of the novel IMP-38 among carbapenemase-producing Enterobacteriaceae in a university hospital, China

Z Jian, Y Li, W Liu, H Li, Y Zhang, Y Li, X Gu… - The Journal of Infection in …, 2014 - jidc.org
Introduction: This study set out to investigate the molecular epidemiology of carbapenemase-
producing Enterobacteriaceae isolates collected from Xiang Ya Hospital, Hunan, China …

[HTML][HTML] Differences in antimicrobial susceptibility testing complicating management of IMP carbapenemase-producing Enterobacterales infection

C Hickey, S Nguyen, J Anes, D Hurley… - Journal of global …, 2021 - Elsevier
Objectives IMP-type carbapenemases are rarely detected in Europe and limited information
is available to guide the treatment of infections caused by carbapenemase-producing …